A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

NCT03710486 · clinicaltrials.gov ↗
COMPLETED
Status
409
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Takeda